Abstract
Twelve laryngeal squamous cell carcinoma cases (7 laryngeal and 5 hypopharyngeal cancer; 15 samples) were analysed by immunohistochemistry for the expression of invasion markers CD44v6/v3, NM23 and matrix metalloproteinase, MMP2. The laryngeal epithelium showed CD44v6+v3+NM23- /MMP2- phenotype. When tumors were grouped into TNM categories the phenotype of the T2 and T3 tumors was similar, characterised by decreased CD44v3+ and lack of MMP2 expressions. Meanwhile the NM23 expression was more frequent in T3 tumors. In T4 stage the frequency of NM23 and MMP2 positive cases increased (5/6 and 4/6, respectively) but there was no correlation with the appearence of lymph node metastasis. Comparison of the phenotype of laryngeal and hypopharyngeal tumors, irrespective of the TNM stages, revealed characteristic differences: T2 stage laryngeal tumors showed decreased CD44v3 and occasional NM23 and MMP2 positivity, while in T3 stage these tumors were characterised by increased frequency of NM23 positivity. The phenotype of the hypopharyngeal tumors was significantly different with a high frequency of MMP2 positive cases (5/6) and NM23+1ow CD44v3+ phenotype. The sharp differences in the phenotypes of laryngeal and hypopharyngeal carcinomas were connected to the differences in their invasive capacity unlike to the size of the tumors, since the T4 stage hypopharyngeal tumors had a significantly smaller size than laryngeal ones, even at lower stages.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Starkey JR: Cell-matrix interactions during tumor invasion. Cancer Metast Rev 9:113–123, 1990.
Kavanaugh DY, Carbone DP: Immunologic dysfunctions in cancer. Haematol Oncol Clin North Am 10:927–951, 1996.
Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12:325–343, 1993.
Günthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastastatic potential to rat carcinoma cells. Cell 65:13–24, 1991.
Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metast 9:391–405, 1989.
Steeg PS, Bevilaqua G, Kopper L, et al: Evidence for a novel gene associated with low tumour metastastatic potential. J Natl Canc Inst 80:200–204, 1988.
Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation. Cell 64:327–336, 1991.
McDonald JS, Gartside PS, Pavelic LJ, et al: NM23-H1 expression in squamous cell carcinoma of the head and neck. Pathol Oncol Res 2:34–36, 1996.
Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ: Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading and proliferation markers. Ann Otol Rhinol Laryngol 104:503–510, 1995.
Maurizi M, Almadori G, Ferrandina G, et al: Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253–57, 1996.
Spafford MF, Koeppe J, Pan Z, et al: Correlation of tumor markers p53, bcl2, CD34, CD44H,CD44v6 and ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122:627–632, 1996.
Russo A, Bazan V,Gebbia N, et al: Flow cytometric DNA analysis and lysosomal cathepsin B and L in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance. Cancer 76:1757–1764, 1995.
Pulkkinen JO, Penttinen M, Jalkanen M, et al: Syndecan-1: new prognostic marker in laryngeal cancer. Acta Otolaryngol Stockh 117:312–315, 1997.
Jackson DG, Bell JI, Dickinson R, et al: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673–685, 1995.
Kovacs L, Szende B, Elek G, et al: Working experience with a new vacuum-accelerated microwave histoprocessor. J Pathol 180:106–110, 1996.
Tímár J, Tóvári J, Pogány G, et al: The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumor cells. Eur J Cancer 32A: 152–159, 1996.
Gotley DC, Fawcett J, Walsh MD, et al: Alternatively spliced variants of the cell adhesion molecule CD44 and tumor progression in colorectal cancer. Br J Cancer 74:342–351, 1996.
Lydiatt WM, Schantz SP: Biological staging of neck cancer and its role in developing effective treatment strategies. Cancer Metast Rev 15:11–25, 1996.
Papadimitrakopoulou VA, Shin DM, Hong WK: Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis. Cancer Metast Rev 15:53–76, 1996.
Piffkó J, Bánkfalvy á, Öfner D, et al: Proliferative (MIB1, mdm2) versus anti-proliferative (p53) markers in head and neck cancer. An immunohistochemical study: Pathol Oncol Res 2:37–42, 1996.
Kusukawa J, Sasguri Y, Shima I, et al: Expression of matrix metalloproteinase-2 related lymph node metastasis of oral squamous cell carcinoma: a clinicopathologic study. Am J Clin Pathol 99:18–23, 1993.
Répássy G, Czigner J, Ribári O, Lapis K: The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma. Arc Otorhinolaryngol 246:151–154, 1988.
Author information
Authors and Affiliations
Additional information
This work was supported by the Hungarian Ministry of Welfare: ETT No: T-11-100/93
Rights and permissions
About this article
Cite this article
RÉPÁssy, G., Forster-HorvÁth, C., JuhÁsz, A. et al. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol. Oncol. Res. 4, 14–21 (1998). https://doi.org/10.1007/BF02904689
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02904689